IgG reactivity with 40-35 kDa soluble and membrane antigen of Strongyloides venezuelensis in immunocompromised patients

Carregando...
Imagem de Miniatura
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2019
Editora
ELSEVIER SCIENCE BV
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
ACTA TROPICA, v.190, p.357-360, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Immunocompromised patients constitute a risk group for the development of severe clinical forms of human strongyloidiasis. The diagnosis of this infection is primarily performed by parasitological techniques, but with low sensitivity. Serological techniques appear as an alternative, especially with heterologous antigens use. The aim of this study was to perform the Western blot technique by using S. venezuelensis infective third stage larva (iL3) soluble (TS) and membrane (TM) saline antigens to reveal immunoreactive bands in immunocompromised patients with strongyloidiasis. Serum samples from 117 parasitologically well-characterized patients were divided into four groups: S. stercoralis positive and immunocompetent (S + IC); S. stercoralis positive and immunocompromised (S + IP); negative and immunocompetent (S-IC); negative and immunocompromised (S-IP). A 40-35 kDa band was recognized by 100% of patients in the S + IC group in both antigenic fractions, and by 62.5% and 50% in the S + IP group using the TS and TM fractions, respectively. A 29 kDa band was recognized by 86.3% and 72.7% (for TS and TM, respectively) of patients in the S + IC group, and only by 12.5% of patients in the S + IP group on the TM antigen. Regardless of the patients' immunological condition, the 40-35 kDa band from S. venezuelensis was detected more frequently and can be used as an important marker to the immunodiagnosis of human strongyloidiasis.
Palavras-chave
Strongyloides venezuelensis, 40-35 kDa band, Immunocompromised patients
Referências
  1. Arifin N, 2018, AM J TROP MED HYG, V98, P1165, DOI 10.4269/ajtmh.17-0697
  2. Batista MV, 2011, TROP MED INT HEALTH, V16, P1134, DOI 10.1111/j.1365-3156.2011.02816.x
  3. Bosqui LR, 2015, ACTA TROP, V150, P190, DOI 10.1016/j.actatropica.2015.07.026
  4. CONWAY DJ, 1993, J INFECT DIS, V168, P784, DOI 10.1093/infdis/168.3.784
  5. Corral MA, 2017, PARASITOLOGY, V144, P124, DOI 10.1017/S0031182016001645
  6. Corral MA, 2015, REV INST MED TROP SP, V57, P77, DOI 10.1590/S0036-46652015000100011
  7. Costa-Cruz Julia Maria, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P265, DOI 10.1590/S0036-46652003000500005
  8. Cunha RA, 2017, PARASITOL INT, V66, P671, DOI 10.1016/j.parint.2017.07.001
  9. Ditgen D, 2018, MOL BIOCHEM PARASIT, V225, P73, DOI 10.1016/j.molbiopara.2018.08.008
  10. Fardet L, 2006, CLIN MICROBIOL INFEC, V12, P945, DOI 10.1111/j.1469-0691.2006.01443.x
  11. Garcia LS, 2001, DIAGNOSTIC MED PARAS
  12. Gonzaga HT, 2011, IMMUNOL LETT, V139, P87, DOI 10.1016/j.imlet.2011.05.006
  13. Grove DI, 1996, ADV PARASIT, V38, P251, DOI 10.1016/S0065-308X(08)60036-6
  14. Guerrero-Wooley R, 2017, AM J TROP MED HYG, V97, P1629, DOI 10.4269/ajtmh.17-0492
  15. Ines ED, 2013, DIAGN MICR INFEC DIS, V76, P31, DOI 10.1016/j.diagmicrobio.2013.01.016
  16. KOGA K, 1991, AM J TROP MED HYG, V45, P518, DOI 10.4269/ajtmh.1991.45.518
  17. Levenhagen MA, 2014, ACTA TROP, V135, P33, DOI 10.1016/j.actatropica.2014.03.015
  18. Machado ER, 2008, EXP PARASITOL, V119, P7, DOI 10.1016/j.exppara.2007.12.008
  19. Olsen A, 2009, T ROY SOC TROP MED H, V103, P967, DOI 10.1016/j.trstmh.2009.02.013
  20. Requena-Mendez A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002002
  21. Rodpai R, 2017, PARASITOL RES, V116, P1687, DOI 10.1007/s00436-017-5443-9
  22. Rodpai R, 2016, PARASITOL RES, V115, P4007, DOI 10.1007/s00436-016-5170-7
  23. Siddiqui AA, 1997, PARASITOL RES, V83, P655, DOI 10.1007/s004360050314
  24. Silva LP, 2003, MEM I OSWALDO CRUZ, V98, P687, DOI 10.1590/S0074-02762003000500017
  25. Silva MLS, 2016, ACTA TROP, V154, P133, DOI 10.1016/j.actatropica.2015.11.010
  26. Teixeira MCA, 2016, BIOMED RES INT, DOI 10.1155/2016/4872473
  27. Toledo R, 2015, ADV PARASIT, V88, P165, DOI 10.1016/bs.apar.2015.02.005
  28. Uparanukraw P, 1999, AM J TROP MED HYG, V60, P967, DOI 10.4269/ajtmh.1999.60.967